<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p21" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_21{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_21{left:341px;bottom:30px;}
#t3_21{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_21{left:377px;bottom:30px;}
#t5_21{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_21{left:540px;bottom:30px;}
#t7_21{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_21{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_21{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_21{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_21{left:285px;bottom:827px;letter-spacing:-0.25px;}
#tc_21{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_21{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_21{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_21{left:1086px;bottom:28px;letter-spacing:0.17px;}
#tg_21{left:36px;bottom:760px;letter-spacing:0.48px;}
#th_21{left:36px;bottom:741px;letter-spacing:0.25px;}
#ti_21{left:115px;bottom:749px;}
#tj_21{left:240px;bottom:760px;letter-spacing:0.32px;word-spacing:-0.31px;}
#tk_21{left:872px;bottom:760px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tl_21{left:36px;bottom:591px;letter-spacing:-0.18px;}
#tm_21{left:36px;bottom:573px;letter-spacing:-0.17px;}
#tn_21{left:36px;bottom:554px;letter-spacing:-0.17px;}
#to_21{left:36px;bottom:536px;letter-spacing:-0.17px;}
#tp_21{left:36px;bottom:518px;letter-spacing:-0.18px;}
#tq_21{left:36px;bottom:499px;letter-spacing:-0.18px;}
#tr_21{left:36px;bottom:481px;letter-spacing:-0.19px;}
#ts_21{left:36px;bottom:463px;letter-spacing:-0.18px;}
#tt_21{left:36px;bottom:444px;letter-spacing:-0.11px;}
#tu_21{left:245px;bottom:711px;letter-spacing:-0.1px;}
#tv_21{left:504px;bottom:719px;letter-spacing:-0.1px;}
#tw_21{left:245px;bottom:654px;letter-spacing:-0.1px;}
#tx_21{left:245px;bottom:574px;letter-spacing:-0.09px;}
#ty_21{left:245px;bottom:555px;letter-spacing:-0.08px;}
#tz_21{left:245px;bottom:537px;letter-spacing:-0.1px;}
#t10_21{left:371px;bottom:545px;letter-spacing:-0.1px;}
#t11_21{left:245px;bottom:331px;letter-spacing:-0.1px;}
#t12_21{left:245px;bottom:304px;letter-spacing:-0.08px;}
#t13_21{left:489px;bottom:635px;letter-spacing:-0.1px;}
#t14_21{left:489px;bottom:617px;letter-spacing:-0.09px;}
#t15_21{left:644px;bottom:625px;letter-spacing:-0.48px;}
#t16_21{left:489px;bottom:505px;letter-spacing:-0.09px;}
#t17_21{left:489px;bottom:487px;letter-spacing:-0.09px;}
#t18_21{left:554px;bottom:495px;letter-spacing:-0.48px;}
#t19_21{left:674px;bottom:552px;letter-spacing:-0.09px;}
#t1a_21{left:674px;bottom:534px;letter-spacing:-0.09px;}
#t1b_21{left:674px;bottom:516px;letter-spacing:-0.1px;}
#t1c_21{left:672px;bottom:462px;letter-spacing:-0.08px;}
#t1d_21{left:672px;bottom:444px;letter-spacing:-0.09px;}
#t1e_21{left:737px;bottom:451px;letter-spacing:-0.48px;}
#t1f_21{left:872px;bottom:552px;letter-spacing:-0.09px;}
#t1g_21{left:872px;bottom:534px;letter-spacing:-0.1px;}
#t1h_21{left:959px;bottom:542px;letter-spacing:-0.11px;}
#t1i_21{left:872px;bottom:484px;letter-spacing:-0.13px;}
#t1j_21{left:894px;bottom:492px;letter-spacing:-0.12px;}
#t1k_21{left:872px;bottom:466px;letter-spacing:-0.1px;}
#t1l_21{left:872px;bottom:448px;letter-spacing:-0.1px;}
#t1m_21{left:872px;bottom:429px;letter-spacing:-0.1px;}
#t1n_21{left:959px;bottom:437px;letter-spacing:-0.12px;}
#t1o_21{left:1067px;bottom:653px;letter-spacing:-0.1px;}
#t1p_21{left:1067px;bottom:635px;letter-spacing:-0.09px;}
#t1q_21{left:1067px;bottom:617px;letter-spacing:-0.08px;}
#t1r_21{left:1068px;bottom:572px;letter-spacing:-0.09px;}
#t1s_21{left:1068px;bottom:554px;letter-spacing:-0.06px;}
#t1t_21{left:1068px;bottom:536px;letter-spacing:-0.08px;}
#t1u_21{left:1068px;bottom:517px;letter-spacing:-0.1px;}
#t1v_21{left:1068px;bottom:499px;letter-spacing:-0.25px;}
#t1w_21{left:872px;bottom:720px;letter-spacing:-0.09px;}
#t1x_21{left:872px;bottom:702px;letter-spacing:-0.09px;}
#t1y_21{left:938px;bottom:702px;letter-spacing:-0.25px;}
#t1z_21{left:36px;bottom:280px;}
#t20_21{left:42px;bottom:274px;letter-spacing:0.12px;word-spacing:-0.1px;}
#t21_21{left:45px;bottom:260px;letter-spacing:0.1px;word-spacing:0.02px;}
#t22_21{left:45px;bottom:247px;letter-spacing:0.1px;word-spacing:0.02px;}
#t23_21{left:45px;bottom:233px;letter-spacing:0.11px;}
#t24_21{left:45px;bottom:219px;letter-spacing:0.13px;}
#t25_21{left:36px;bottom:211px;}
#t26_21{left:46px;bottom:205px;letter-spacing:0.13px;}
#t27_21{left:261px;bottom:205px;}
#t28_21{left:36px;bottom:197px;}
#t29_21{left:42px;bottom:192px;letter-spacing:0.11px;word-spacing:0.01px;}
#t2a_21{left:45px;bottom:178px;letter-spacing:0.12px;}
#t2b_21{left:45px;bottom:164px;letter-spacing:0.12px;}
#t2c_21{left:36px;bottom:156px;}
#t2d_21{left:46px;bottom:150px;letter-spacing:0.13px;word-spacing:-0.06px;}
#t2e_21{left:332px;bottom:150px;}
#t2f_21{left:36px;bottom:142px;}
#t2g_21{left:46px;bottom:137px;letter-spacing:0.13px;word-spacing:-0.05px;}
#t2h_21{left:45px;bottom:123px;letter-spacing:0.08px;word-spacing:0.06px;}
#t2i_21{left:171px;bottom:123px;}
#t2j_21{left:36px;bottom:115px;}
#t2k_21{left:46px;bottom:109px;letter-spacing:0.12px;}
#t2l_21{left:78px;bottom:109px;letter-spacing:0.12px;}
#t2m_21{left:156px;bottom:109px;letter-spacing:0.08px;word-spacing:0.05px;}
#t2n_21{left:471px;bottom:336px;}
#t2o_21{left:478px;bottom:330px;letter-spacing:0.1px;word-spacing:0.02px;}
#t2p_21{left:480px;bottom:316px;letter-spacing:0.12px;word-spacing:-0.06px;}
#t2q_21{left:1116px;bottom:316px;letter-spacing:-0.13px;}
#t2r_21{left:1148px;bottom:316px;letter-spacing:0.08px;}
#t2s_21{left:471px;bottom:308px;}
#t2t_21{left:480px;bottom:302px;letter-spacing:0.12px;}
#t2u_21{left:480px;bottom:289px;letter-spacing:0.11px;word-spacing:0.01px;}
#t2v_21{left:480px;bottom:275px;letter-spacing:0.1px;word-spacing:0.02px;}
#t2w_21{left:923px;bottom:275px;letter-spacing:0.13px;}
#t2x_21{left:997px;bottom:275px;letter-spacing:0.11px;word-spacing:-0.07px;}
#t2y_21{left:480px;bottom:261px;letter-spacing:0.12px;word-spacing:-0.01px;}
#t2z_21{left:480px;bottom:247px;letter-spacing:0.12px;}
#t30_21{left:471px;bottom:240px;}
#t31_21{left:478px;bottom:234px;letter-spacing:0.12px;}
#t32_21{left:480px;bottom:220px;letter-spacing:0.12px;}
#t33_21{left:471px;bottom:212px;}
#t34_21{left:481px;bottom:206px;letter-spacing:0.13px;}
#t35_21{left:480px;bottom:192px;letter-spacing:0.13px;word-spacing:-0.01px;}
#t36_21{left:480px;bottom:179px;letter-spacing:0.11px;word-spacing:0.01px;}
#t37_21{left:480px;bottom:165px;letter-spacing:0.12px;}
#t38_21{left:471px;bottom:157px;}
#t39_21{left:480px;bottom:151px;letter-spacing:0.12px;}
#t3a_21{left:480px;bottom:137px;letter-spacing:0.12px;word-spacing:0.01px;}
#t3b_21{left:471px;bottom:130px;}
#t3c_21{left:483px;bottom:124px;letter-spacing:0.12px;}
#t3d_21{left:480px;bottom:110px;letter-spacing:0.08px;word-spacing:0.05px;}
#t3e_21{left:36px;bottom:778px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t3f_21{left:245px;bottom:397px;letter-spacing:-0.1px;}
#t3g_21{left:440px;bottom:404px;letter-spacing:-0.11px;}
#t3h_21{left:245px;bottom:379px;letter-spacing:-0.09px;}
#t3i_21{left:464px;bottom:386px;}
#t3j_21{left:245px;bottom:360px;letter-spacing:-0.1px;}
#t3k_21{left:430px;bottom:368px;letter-spacing:-0.12px;}
#t3l_21{left:245px;bottom:463px;letter-spacing:-0.1px;}
#t3m_21{left:515px;bottom:390px;letter-spacing:-0.1px;}
#t3n_21{left:515px;bottom:370px;letter-spacing:-0.09px;}
#t3o_21{left:872px;bottom:389px;letter-spacing:-0.09px;}
#t3p_21{left:872px;bottom:371px;letter-spacing:-0.09px;}
#t3q_21{left:938px;bottom:371px;letter-spacing:-0.25px;}
#t3r_21{left:605px;bottom:732px;letter-spacing:-0.1px;}
#t3s_21{left:605px;bottom:713px;letter-spacing:-0.1px;}
#t3t_21{left:605px;bottom:695px;letter-spacing:-0.09px;}
#t3u_21{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_21{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_21{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_21{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_21{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_21{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_21{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_21{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_21{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s8_21{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s9_21{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.sa_21{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sb_21{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sc_21{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sd_21{font-size:14px;font-family:Arial-BoldMT_jz;color:#000;}
.se_21{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts21" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg21Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg21" style="-webkit-user-select: none;"><object width="1210" height="935" data="21/21.svg" type="image/svg+xml" id="pdf21" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_21" class="t s0_21">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_21" class="t s1_21">® </span>
<span id="t3_21" class="t s0_21">(NCCN </span>
<span id="t4_21" class="t s1_21">® </span>
<span id="t5_21" class="t s0_21">), All rights reserved. NCCN Guidelines </span>
<span id="t6_21" class="t s1_21">® </span>
<span id="t7_21" class="t s0_21">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_21" class="t s2_21">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_21" class="t s2_21">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_21" class="t s3_21">NCCN Guidelines Version 4.2024 </span>
<span id="tb_21" class="t s3_21">Cancer of the Oropharynx (p16 [HPV]-positive) </span>
<span id="tc_21" class="t s4_21">NCCN Guidelines Index </span>
<span id="td_21" class="t s4_21">Table of Contents </span>
<span id="te_21" class="t s4_21">Discussion </span>
<span id="tf_21" class="t s5_21">ORPHPV-3 </span>
<span id="tg_21" class="t s5_21">CLINICAL </span>
<span id="th_21" class="t s5_21">STAGING </span>
<span id="ti_21" class="t s6_21">j </span>
<span id="tj_21" class="t s5_21">TREATMENT OF PRIMARY AND NECK </span><span id="tk_21" class="t s5_21">ADJUVANT TREATMENT </span>
<span id="tl_21" class="t s5_21">p16 (HPV)-positive </span>
<span id="tm_21" class="t s5_21">T0–2,N1 (single </span>
<span id="tn_21" class="t s5_21">node &gt;3 cm, or 2 </span>
<span id="to_21" class="t s5_21">or more ipsilateral </span>
<span id="tp_21" class="t s7_21">nodes ≤6 cm), </span>
<span id="tq_21" class="t s5_21">or </span>
<span id="tr_21" class="t s5_21">T0–2,N2 </span>
<span id="ts_21" class="t s5_21">or </span>
<span id="tt_21" class="t s5_21">T3,N0–2 </span>
<span id="tu_21" class="t s5_21">Concurrent systemic therapy/RT </span>
<span id="tv_21" class="t s6_21">n,o,v </span>
<span id="tw_21" class="t s5_21">or </span>
<span id="tx_21" class="t s5_21">Resection of primary and </span>
<span id="ty_21" class="t s5_21">ipsilateral or bilateral </span>
<span id="tz_21" class="t s5_21">neck dissection </span>
<span id="t10_21" class="t s6_21">k,l,v </span>
<span id="t11_21" class="t s5_21">or </span>
<span id="t12_21" class="t s5_21">Clinical trials </span>
<span id="t13_21" class="t s5_21">No adverse </span>
<span id="t14_21" class="t s5_21">pathologic features </span>
<span id="t15_21" class="t s6_21">r,s </span>
<span id="t16_21" class="t s5_21">Adverse pathologic </span>
<span id="t17_21" class="t s5_21">features </span>
<span id="t18_21" class="t s6_21">r,s </span>
<span id="t19_21" class="t s5_21">Extranodal </span>
<span id="t1a_21" class="t s5_21">extension and/or </span>
<span id="t1b_21" class="t s5_21">positive margin </span>
<span id="t1c_21" class="t s5_21">Other risk </span>
<span id="t1d_21" class="t s5_21">features </span>
<span id="t1e_21" class="t s6_21">r,s </span>
<span id="t1f_21" class="t s5_21">Systemic </span>
<span id="t1g_21" class="t s5_21">therapy/RT </span>
<span id="t1h_21" class="t s6_21">n,o,t </span>
<span id="t1i_21" class="t s5_21">RT </span>
<span id="t1j_21" class="t s6_21">n,u </span>
<span id="t1k_21" class="t s5_21">or </span>
<span id="t1l_21" class="t s5_21">Consider systemic </span>
<span id="t1m_21" class="t s5_21">therapy/RT </span>
<span id="t1n_21" class="t s6_21">n,o </span>
<span id="t1o_21" class="t s5_21">Follow-up </span>
<span id="t1p_21" class="t s8_21">(FOLL-A, 1 </span>
<span id="t1q_21" class="t s8_21">of 2) </span>
<span id="t1r_21" class="t s5_21">Recurrent </span>
<span id="t1s_21" class="t s5_21">or </span>
<span id="t1t_21" class="t s5_21">persistent </span>
<span id="t1u_21" class="t s5_21">disease </span>
<span id="t1v_21" class="t s8_21">(ADV-3) </span>
<span id="t1w_21" class="t s5_21">Recurrent or persistent </span>
<span id="t1x_21" class="t s5_21">disease </span><span id="t1y_21" class="t s8_21">(ADV-3) </span>
<span id="t1z_21" class="t s9_21">j </span>
<span id="t20_21" class="t sa_21">The clinical staging definitions are based on the AJCC </span>
<span id="t21_21" class="t sa_21">8th edition for oropharynx cancer (see ST-4 for p16-, and </span>
<span id="t22_21" class="t sb_21">see ST-7 for p16+). Definitions for nodal staging criteria </span>
<span id="t23_21" class="t sa_21">previously used in clinical trials (AJCC 7th edition) on the </span>
<span id="t24_21" class="t sa_21">management of oropharynx cancer are included. </span>
<span id="t25_21" class="t s9_21">k </span>
<span id="t26_21" class="t sc_21">Principles of Surgery (SURG-A)</span><span id="t27_21" class="t sa_21">. </span>
<span id="t28_21" class="t s9_21">l </span>
<span id="t29_21" class="t sa_21">Tumors in the base of tongue, posterior pharyngeal wall, and </span>
<span id="t2a_21" class="t sa_21">soft palate require consideration of bilateral neck treatment </span>
<span id="t2b_21" class="t sa_21">as do tumors of the tonsil invading the tongue base. </span>
<span id="t2c_21" class="t s9_21">n </span>
<span id="t2d_21" class="t sc_21">Principles of Radiation Therapy (ORPH-A)</span><span id="t2e_21" class="t sa_21">. </span>
<span id="t2f_21" class="t s9_21">o </span>
<span id="t2g_21" class="t sc_21">Principles of Systemic Therapy for Non-Nasopharyngeal </span>
<span id="t2h_21" class="t sc_21">Cancers (SYST-A)</span><span id="t2i_21" class="t sa_21">. </span>
<span id="t2j_21" class="t s9_21">q </span>
<span id="t2k_21" class="t sa_21">See </span><span id="t2l_21" class="t sc_21">Discussion </span><span id="t2m_21" class="t sa_21">on induction chemotherapy. </span>
<span id="t2n_21" class="t s9_21">r </span>
<span id="t2o_21" class="t sa_21">Pathologic staging criteria differ from clinical staging criteria in HPV-mediated oropharyngeal cancer. </span>
<span id="t2p_21" class="t sa_21">For pathologic stage following resection, see AJCC 8th edition for appropriate staging criteria (</span><span id="t2q_21" class="t sc_21">ST-7</span><span id="t2r_21" class="t sa_21">). </span>
<span id="t2s_21" class="t s9_21">s </span>
<span id="t2t_21" class="t sa_21">Adverse pathologic features: extranodal extension, positive margins, close margins (&lt;3 mm), pT3 </span>
<span id="t2u_21" class="t sa_21">or pT4 primary, one positive node &gt;3 cm or multiple positive nodes, nodal disease in levels IV or </span>
<span id="t2v_21" class="t sa_21">V, perineural invasion, vascular invasion, and lymphatic invasion (</span><span id="t2w_21" class="t sc_21">Discussion</span><span id="t2x_21" class="t sa_21">). The definition of an </span>
<span id="t2y_21" class="t sb_21">adverse pathologic feature in the context of HPV+ disease is an area of active research. This includes </span>
<span id="t2z_21" class="t sa_21">the presence and extent of extranodal extension, and the number of involved nodes. </span>
<span id="t30_21" class="t s9_21">t </span>
<span id="t31_21" class="t sb_21">The recommendations for patients at high risk with extranodal extension + positive margins are based </span>
<span id="t32_21" class="t sb_21">on randomized studies involving patients for whom the HPV status of their tumors was not specified. </span>
<span id="t33_21" class="t s9_21">u </span>
<span id="t34_21" class="t sa_21">De-escalation to 50 Gy may be considered in patients with p16 (HPV)-positive oropharynx cancer </span>
<span id="t35_21" class="t sa_21">who have up to 4 positive lymph nodes, T1–T2 resected to negative or close margins (&lt;3 mm), and/ </span>
<span id="t36_21" class="t sb_21">or N1–N2 disease (excluding bilateral disease based on ECOG 3311 criteria) with ≤1 mm extranodal </span>
<span id="t37_21" class="t sa_21">extension (Ferris R, et al. J Clin Oncol 2022;40:138-149) (category 2B) </span>
<span id="t38_21" class="t s9_21">v </span>
<span id="t39_21" class="t sa_21">For those with clinical evidence of fixed or matted nodes or obvious extranodal extension, resection is </span>
<span id="t3a_21" class="t sa_21">not recommended and concurrent systemic therapy/RT is preferred. </span>
<span id="t3b_21" class="t s9_21">w </span>
<span id="t3c_21" class="t sa_21">Surgical intervention may be an option for select patients with disease that does not respond to </span>
<span id="t3d_21" class="t sa_21">induction chemotherapy. </span>
<span id="t3e_21" class="t s5_21">Base of Tongue/Tonsil/Posterior Pharyngeal Wall/Soft Palate </span>
<span id="t3f_21" class="t s5_21">Induction chemotherapy </span>
<span id="t3g_21" class="t sd_21">o,q,w </span>
<span id="t3h_21" class="t s5_21">(category 3) followed by RT </span>
<span id="t3i_21" class="t s6_21">n </span>
<span id="t3j_21" class="t s5_21">or systemic therapy/RT </span>
<span id="t3k_21" class="t s6_21">n,o </span>
<span id="t3l_21" class="t s5_21">or </span>
<span id="t3m_21" class="t s8_21">Post Systemic Therapy/RT or RT </span>
<span id="t3n_21" class="t s8_21">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t3o_21" class="t s5_21">Recurrent or persistent </span>
<span id="t3p_21" class="t s5_21">disease </span><span id="t3q_21" class="t s8_21">(ADV-3) </span>
<span id="t3r_21" class="t s8_21">Post Systemic Therapy/ </span>
<span id="t3s_21" class="t s8_21">RT or RT Neck Evaluation </span>
<span id="t3t_21" class="t s8_21">(FOLL-A, 2 of 2) </span>
<span id="t3u_21" class="t se_21">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
